XM does not provide services to residents of the United States of America.
A
A

Abbott


News

Insulet Announces Omnipod 5 System Is Now Compatible With Abbott’S Freestyle Libre 2 Plus Sensor In The US

BRIEF-Insulet Announces Omnipod 5 System Is Now Compatible With Abbott’S Freestyle Libre 2 Plus Sensor In The US Nov 20 (Reuters) - Abbott Laboratories ABT.N : INSULET ANNOUNCES OMNIPOD® 5 SYSTEM IS NOW COMPATIBLE WITH ABBOTT’S FREESTYLE LIBRE 2 PLUS SENSOR IN THE U.S. Source text: ID:nBw49Vv3la Further company coverage: ABT.N
A

UK regulator flags concerns and remedies for sale of baby formula

UPDATE 1-UK regulator flags concerns and remedies for sale of baby formula Adds details throughout Nov 8 (Reuters) - Britain's competition watchdog flagged concerns and potential solutions regarding the distribution of infant formulas on Friday, which could help improve the sector as well as reduce costs for parents. The Competition and Markets Authority's (CMA) initial recommendations include providing parents clear and accurate information on the nutritional value of the formula and standardis
A

UK's CMA Flags Concerns And Remedies For Sale Of Baby Formula

BRIEF-UK's CMA Flags Concerns And Remedies For Sale Of Baby Formula Nov 8 (Reuters) - UK's CMA: INFANT FORMULA: CMA SETS OUT CONCERNS & SOLUTIONS CONCERNS REGARDING INFANT FORMULA MARKET - ALL OF WHICH APPEAR TO BE CONTRIBUTING TO PARENTS PAYING OVER ODDS SETTING OUT A NUMBER OF POTENTIAL OPTIONS THAT COULD HELP IMPROVE SECTOR AND REDUCE COSTS FOR PARENTS POTENTIAL OPTIONS INCLUDE PROVIDING CLEAR, ACCURATE, AND IMPARTIAL INFORMATION POTENTIAL OPTIONS INCLUDE STRENGTHENING LABELLING AND ADVERTISI
A

UK regulator flags concerns and remedies for sale of baby formula

UK regulator flags concerns and remedies for sale of baby formula Nov 8 (Reuters) - Britain's competition watchdog flagged concerns and potential solutions regarding the distribution of infant formulas on Friday, which could help improve the sector as well as manage costs for parents. Reporting by Yamini Kalia in Bengaluru; Editing by Rashmi Aich
A

Becton Dickinson beats quarterly estimates on strength in drug-delivery devices

Becton Dickinson beats quarterly estimates on strength in drug-delivery devices Nov 7 (Reuters) - Becton Dickinson BDX.N surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices. Medical technology firms such as Becton, Boston Scientific BSX.N and Abbott Laboratories ABT.N have been benefiting from robust demand for non-essential surgical procedures, especially among older patients.
A
B

Abbott India posts Q2 profit rise on strong demand, price hikes

Abbott India posts Q2 profit rise on strong demand, price hikes Nov 7 (Reuters) - Drugmaker Abbott India ABOT.NS reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications. The company, which makes the antacid Digene, reported a profit of 3.59 billion rupees ($42.6 million) for the quarter ended Sept.
A
G
P

India economic, corporate events on November 7

DIARY- India economic, corporate events on November 7 BENGALURU, Nov 7 (Reuters) - Diary of India economic, corporate events on November 7. ECONOMIC, CORPORATE .BSE500 EVENTS: Key Speaker Local Time Location India policy think tank chief 0930 Industry body ASSOCHAM event, New Delhi Start Date Start Time RIC Company Name Event Name 07-Nov-2024 NTS ABOT.NS Abbott India Ltd Q2 2025 Abbott India Ltd Earnings Release 07-Nov-2024 NTS ADIA.NS Aditya Birla Fashion and Retail Ltd Q2 2025 Aditya Birla Fas
A
N
A
C

U.S. Celanese Corporation, Disc Medicine, Editas Medicine

U.S. RESEARCH ROUNDUP-Celanese Corporation, Disc Medicine, Editas Medicine Nov 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Celanese Corporation, Disc Medicine and Editas Medicine, on Tuesday. HIGHLIGHTS * Affiliated Managers Group Inc AMG.N : TD Cowen cuts to hold from buy * Celanese Corporation CE.N : Wells Fargo cuts to equal weight from overweight * Disc Medicine Inc IRON.O : Raymond James raises to strong b
A
A
B
C
C
E
H
I
M
V
W
E
F
B
C

Abbott Laboratories Late-Breaking Data Shows Sustained Benefits Of Esprit Btk System

BRIEF-Abbott Laboratories Late-Breaking Data Shows Sustained Benefits Of Esprit Btk System Nov 4 (Reuters) - Abbott Laboratories ABT.N : ABBOTT -LATE-BREAKING DATA SHOWS SUSTAINED BENEFITS OF ABBOTT'S ESPRIT BTK SYSTEM FOR PEOPLE BATTLING PERIPHERAL ARTERY DISEASE BELOW THE KNEE ABBOTT - DATA SHOWED SUSTAINED SAFETY & EFFICACY OF ESPRIT BTK IN TREA
A

FTSE 100 rebounds on Reckitt boost but logs weekly decline

UPDATE 1-FTSE 100 rebounds on Reckitt boost but logs weekly decline FTSE 100 up 0.8%, FTSE 250 up 0.5% Reckitt up after clearance in preterm formula case Focus on U.S. election next week BoE rate decision on Nov. 7 Updated at 1632 GMT By Sruthi Shankar and Nikhil Sharma Nov 1 (Reuters) - The UK's FTSE 100 rebounded on Friday from near three-month lows touched in the prior session, as gains in Reckitt Benckiser helped offset concerns about inflation sparked by the first Labour government budget i
A
E
U

U.S. STOCKS Wayfair, B. Riley, Church & Dwight

BUZZ-U.S. STOCKS ON THE MOVE-Wayfair, B. Riley, Church & Dwight Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock futures rose on Friday, buoyed by strong Amazon results offsetting the previous session's tech selloff, with investors awaiting nonfarm payrolls data for insights on the Federal Reserve's key policy rate trajectory.
A
A
A
B
C
I
S
U
I
W
C
H

U.S. STOCKS Intel, Abbott, Boeing

BUZZ-U.S. STOCKS ON THE MOVE-Intel, Abbott, Boeing Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slightly pared gains on Friday after job additions in October were much lower than estimated, while the unemployment rate remained steady.
A
B
C
I
S
U

Abbott shares rise after securing first win in premature infant formula trial

Abbott shares rise after securing first win in premature infant formula trial Nov 1 (Reuters) - Abbott Laboratories ABT.N shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks. A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt RKT.L unit Mead Johnson are not responsible for a young boy's severe intestinal disease, marking the first victory for the companies aft
A

FTSE 100 rebounds as Reckitt and oil stocks offset budget concerns

FTSE 100 rebounds as Reckitt and oil stocks offset budget concerns For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 up 0.6%, FTSE 250 0.2% Oct 28 (Reuters) - The UK's FTSE 100 edged up on Friday from near three-month lows touched in the prior session, as gains in Reckitt Benckiser and oil stocks offset concerns about inflation sparked by Britain's budget.
A
U

Abbott climbs on being cleared of liability in latest preterm formula case

BUZZ-Abbott climbs on being cleared of liability in latest preterm formula case ** Shares of medical device maker Abbott Laboratories ABT.N rise ~5% to $118.94 premarket ** Abbott and British consumer goods company Reckitt's RKT.L unit Mead Johnson cleared of liability in a preterm formula case, accusing them of failing to warn about the risks of t
A

Europe's STOXX 600 jumps 1% as banks lead market rebound, US election in focus

UPDATE 2-Europe's STOXX 600 jumps 1% as banks lead market rebound, US election in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Banks top weekly gainer Reckitt jumps after being cleared in preterm formula case Maersk, Technip Energies rise for second day on outlook boost Fugro slumps after it reports lower revenue in US, Middle East Updates with closing levels By Ankika Biswas and Pranav Kashyap Nov 1 (Reuters) - Europe's main st
A
A
J
L
M
U
E
F
I
S
S
U
G

Reckitt jumps after being cleared in preterm formula case

BUZZ-Reckitt jumps after being cleared in preterm formula case ** Shares in British consumer goods company Reckitt RKT.L surge 11.1% to 5,204 pence, top gainers on the FTSE bluechip index .FTSE ** Abbott ABT.N and Reckitt's RKT.L unit Mead Johnson were cleared of liability in a preterm formula case on Thursday ** Lawsuit had accused the companies f
A
U

UK Stocks-Factors to watch on Nov 1

UPDATE 1-UK Stocks-Factors to watch on Nov 1 Adds new items, updates futures Nov 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat on Friday, with futures FFIc1 up 0 .02%. * BOOHOO: British online fashion retailer Boohoo BOOH.L appointed Dan Finley as its new CEO , effective immediately, to succeed John Lyttle, a week after top investor Frasers FRAS.L wanted its controlling shareholder Mike Ashley in the role.
A

UK Stocks-Factors to watch on Nov 1

UK Stocks-Factors to watch on Nov 1 Nov 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.14%. * UK BONDS: British government bond prices tumbled for a second day on Thursday as investors judged finance minister Rachel Reeves' first budget would boost inflation and cause the Bank of England to cut interest rates more slowly.
A

Abbott rises after being cleared of liability in preterm formula case

BUZZ-Abbott rises after being cleared of liability in preterm formula case ** Shares of medical device maker Abbott Laboratories ABT.N rise 5.4% to $119.5 in after-hours trading ** ABT and Reckitt RKT.L unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, jury finds ** Lawsuit accused ABT and RKT of failing to wa
A



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.